33.1
Intellia Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−268
FY22:
−458
FY23:
−515
FY24:
−534
FY25:
−441
(positive)
Change from FY21 to FY25
millions USD
FY21:
−261
FY22:
−437
FY23:
−506
FY24:
−491
FY25:
−424
(positive)
Change from FY21 to FY25
millions USD
FY21:
−268
FY22:
−474
FY23:
−481
FY24:
−519
FY25:
−413
(positive)
Change from FY21 to FY25
millions USD
FY21:
−268
FY22:
−474
FY23:
−481
FY24:
−519
FY25:
−413
All amounts in millions USD